Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
version: 66; Last updated: 2025-10-07 17:12:54+0000
Profile: ComparatorOnlyEvidence
url: https://fevir.net/resources/Evidence/236550
identifier: FEvIR Object Identifier/236550, outcomeId/313879, picoId/85789, sectionId/73212
name: Nonfatal_stroke_Comparator_Evidence_from_MAGICapp_313879
title: MAGIC-derived ComparatorOnlyEvidence: Nonfatal stroke in Standard care Group in Adults with type 2 diabetes with moderate CV risk
citeAs:
MAGIC-derived ComparatorOnlyEvidence: Nonfatal stroke in Standard care Group in Adults with type 2 diabetes with moderate CV risk [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236550. Revised 2025-10-07. Available at: https://fevir.net/resources/Evidence/236550. Computable resource at: https://fevir.net/resources/Evidence/236550#json.
status: Active
author: Computable Publishing®: MAGIC-to-FEvIR Converter:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
| Code | Value[x] |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | ComparatorOnlyEvidence |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
| Type | Target[x] |
| Part Of | MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report) |
description:
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
note:
From RECODe to an estimate per 1000 patients for 5 years with the following assumption: Non-fatal MI and non-fatal stroke are equally distribute (https://sanjaybasu.shinyapps.io/recode/).
variableDefinition
description:
Adults with type 2 diabetes with moderate CV risk -- Standard care
variableRole: Population
observed: Standard care Group in Adults with type 2 diabetes with moderate CV risk
variableDefinition
description:
Nonfatal stroke
variableRole: Outcome
observed: Nonfatal stroke
synthesisType: NOTSET
studyDesign: NO_STUDY
| Description | StatisticType | Quantity |
Risk 10.8% | proportion | 0.108 |
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot2 based on FHIR 6.0.0-ballot3. Generated 2025-10-11
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change